During the past decade, Alabama Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Alabama Oncology" are "Advanced Breast Cancer" (1 trials), "Breast Cancer With Low to Intermediate HER2 Expression" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Alabama Oncology" in a lesser frequency.

Most popular intervention types in "Alabama Oncology" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Leukine® (sargramostim, GM-CSF) and water for injection" (1 trials), "NeuVax™ vaccine" (1 trials), "carboplatin" (1 trials) and "non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Oncology" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Alabama Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Alabama Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".